BIGG

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2016 revision

Brożek, J. L; Bousquet, J; Agache, I; Agarwal, A; Bachert, C; Bosnic-Anticevich, S; Brignardello-Petersen, R; Canonica, G. W; Casale, T; Chavannes, N. H; Correia de Sousa, J; Cruz, A. A; Cuello-Garcia, C. A; Demoly, P; Dykewicz, M; Etxeandia-Ikobaltzeta, I; Florez, I. D; Fokkens, W; Fonseca, J; Hellings, P. W; Klimek, L; Kowalski, S; Kuna, P; Laisaar, K. T; Larenas-Linnemann, D. E; Lodrup Carlsen, K. C; Manning, P. J; Meltzer, E; Mullol, J; Muraro, A; O'Hehir, R; Ohta, K; Panzner, P; Panzner, P; Papadopoulos, N; Park, H. S; Passalacqua, G; Pawankar, R; Price, D; Riva, J. J; Roldán, Y; Ryan, D; Sadeghirad, B; Samolinski, B; Schmid-Grendelmeier, P; Sheikh, A; Togias, A; Valero, A; Valiulis, A; Valovirta, E; Ventresca, M; Wallace, D; Waserman, S; Wickman, M; Wiercioch, W; Yepes-Nuñez, J. J; Zhang, L; Zhang, Y; Zidarn, M; Zuberbier, T; Schünemann, H. J.

J. allergy clin. immunol; 140 (4), 2017

BACKGROUND: Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of life and school and work performance and is a frequent reason for office visits in general practice. Medical costs are large, but avoidable costs associated with lost work productivity are even larger than thos...

Rinitis Alérgica/tratamiento farmacológico, Antialérgicos/uso terapéutico, Asma/prevención & control, Antagonistas de los Receptores Histamínicos H1/uso terapéutico, Toma de Decisiones Clínicas, Calidad de Vida

Texto completo

World Allergy Organization-McMaster University Guidelines for allergic disease prevention (GLAD-P): vitamin D

BACKGROUND: The prevalence of allergic diseases is approximately 10 % in infants whose parents and siblings do not have allergic diseases and 20-30 % in those with an allergic first-degree relative. Vitamin D is involved in the regulation of the immune system and it may play a role in the development, se...